SUSQUEHANNA INTERNATIONAL GROUP, LLP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$159,513
-41.8%
53,171
-52.3%
0.00%
Q2 2023$274,049
+11.0%
111,402
+2.0%
0.00%
Q1 2023$246,824
-78.0%
109,214
-66.1%
0.00%
Q4 2022$1,124,112
-96.5%
322,095
-63.3%
0.00%
-100.0%
Q3 2022$32,519,000
+344.6%
878,418
+128.0%
0.01%
+300.0%
Q2 2022$7,315,000
+75.4%
385,200
+149.3%
0.00%
+100.0%
Q1 2022$4,170,000
-9.7%
154,500
-24.6%
0.00%
Q4 2021$4,618,000
+84.6%
204,910
+114.7%
0.00%
Q3 2021$2,501,000
-62.0%
95,430
-53.5%
0.00%
Q2 2021$6,574,000
+17.7%
205,361
+29.4%
0.00%
Q1 2021$5,587,000
+57.6%
158,678
+43.6%
0.00%
Q4 2020$3,544,000
+43.6%
110,512
+68.5%
0.00%
Q3 2020$2,468,000
-34.2%
65,600
-21.7%
0.00%
-100.0%
Q2 2020$3,750,000
+1.3%
83,800
-22.8%
0.00%0.0%
Q1 2020$3,703,000
+109.2%
108,566
+139.1%
0.00%
Q4 2019$1,770,00045,3990.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders